Lorazepam vs Pembrolizumab
Lorazepam vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Lorazepam and Pembrolizumab.
Mechanism of Action
Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Lorazepam — 10-20 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Lorazepam — C15H10Cl2N2O2.
Molecular Weight: Lorazepam — 321.1580 g/mol.
Type: Lorazepam — Small molecule; Pembrolizumab — Antibody.